Literature DB >> 21316013

Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan.

Shih-Jung Cheng1, Jang-Jaer Lee, Sang-Heng Kok, Chia-Hsuan Chou, Hao-Hueng Chang, Hsiang Yang, Meng-Ling Chiang, Mark Yen-Ping Kuo.   

Abstract

BACKGROUND/
PURPOSE: Expression of vascular endothelial growth factor (VEGF) correlates with progression and prognosis of several human cancers. The main purposes of this study were to assess expression of VEGF in specimens of oral squamous cell carcinoma (OSCC) and to evaluate the possible influence of VEGF on the progression and prognosis of OSCC in Taiwan.
METHODS: An immunohistochemical technique was used to examine the expression of VEGF in 100 specimens of OSCC, 66 specimens of oral epithelial dysplasia, and 36 specimens of normal oral mucosa.
RESULTS: We found that the mean labeling indices (Lis) of VEGF increased significantly from normal oral mucosa (13 ± 6%), through mild (22 ± 8%), moderate (24 ± 13%), and severe oral epithelial dysplasia (32 ± 14%), to OSCC samples (50 ± 18%, p < 0.001). The higher mean VEGF LI was significantly related to OSCC with positive lymph node metastasis (p = 0.022) and with more advanced clinical stages (p = 0.046). In addition, positive lymph node metastasis (p = 0.008) and VEGF LI > 40% (p = 0.046) were identified as independent unfavorable prognosis factors for OSCC patients by multivariate analysis with the Cox regression model. Moreover, the Kaplan-Meier curve showed that OSCC patients with a VEGF LI > 40% had a significantly poorer cumulative survival than those with a VEGF LI ≤ 40% (log-rank test, p = 0.016).
CONCLUSION: We conclude that VEGF may be a biomarker for prediction of the progression and prognosis of OSCC in Taiwan.
Copyright © 2011 Formosan Medical Association & Elsevier. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316013     DOI: 10.1016/S0929-6646(11)60008-9

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  8 in total

1.  Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.

Authors:  N D Seibold; S E Schild; K L Bruchhage; M P Gebhard; F Noack; D Rades
Journal:  Strahlenther Onkol       Date:  2013-06-09       Impact factor: 3.621

Review 2.  Immunohistochemical expression of vascular endothelial growth factor in orofacial lesions - A review.

Authors:  Bhavana Gupta; Shaleen Chandra; Vineet Raj; Vivek Gupta
Journal:  J Oral Biol Craniofac Res       Date:  2016-02-19

3.  VEGFA isoforms play a vital role in oral cancer progression.

Authors:  Kinjal R Patel; Bhairavi N Vajaria; Rasheedunnisa Begum; Jayendra B Patel; Franky D Shah; Geeta M Joshi; Prabhudas S Patel
Journal:  Tumour Biol       Date:  2015-03-25

4.  Prognostic significance of VEGF immunohistochemical expression in oral cancer: a meta-analysis of the literature.

Authors:  Su-Feng Zhao; Xu-Dong Yang; Ming-Xing Lu; Guo-Wen Sun; Yu-Xin Wang; Yin-Kai Zhang; Yu-Mei Pu; En-Yi Tang
Journal:  Tumour Biol       Date:  2013-06-05

5.  Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma.

Authors:  Chao Li; Chang-jin Sun; Jin-chuan Fan; Ning Geng; Chun-hua Li; Jian Liao; Kun Mi; Gui-quan Zhu; Hong Ma; Yu-feng Song; Ya-ling Tang; Yu Chen
Journal:  Med Oncol       Date:  2013-05-07       Impact factor: 3.064

6.  Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders.

Authors:  P Sharada; Uma Swaminathan; B R Nagamalini; K Vinod Kumar; B K Ashwini; Vln Lavanya
Journal:  J Oral Maxillofac Pathol       Date:  2018 Jan-Apr

7.  Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.

Authors:  Nabil F Saba; Pooja Vijayvargiya; Jan B Vermorken; Juan P Rodrigo; Stefan M Willems; Nina Zidar; Remco de Bree; Antti Mäkitie; Greg T Wolf; Athanassios Argiris; Yong Teng; Alfio Ferlito
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

8.  Tissue expression, serum and salivary levels of vascular endothelial growth factor in patients with HNSCC.

Authors:  Azadeh Andisheh-Tadbir; Marzieh Hamzavi; Gita Rezvani; Mohammad Javad Ashraf; Mohammad Javad Fattahi; Bijan Khademi; Fereshteh Kamali
Journal:  Braz J Otorhinolaryngol       Date:  2014-08-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.